Leukemia is a systemic and heterogeneous⁽¹⁾ hematological disease, with retinal involvement as the most common ocular manifestation⁽²⁾. Leukemic retinopathy (Figure 1) may arise from direct infiltration or hematologic abnormalities. These manifest as intraretinal or preretinal hemorrhages and cotton-wool spots⁽²⁾. Treatment resolves the retinopathy within the first 2 months⁽²⁾. Management should be individualized based on the patients’ underlying medical condition⁽¹⁾. If untreated, the sequelae include choroidal neovascularization and tractional retinal detachments⁽²⁾.

REFERENCES

1. Ghanbarnia M, Sedaghat S, Rasoulinejad SA. Leukemic retinopathy presenting as concurrent bilateral subhyaloid hemorrhage and subarachnoid hemorrhage in a patient with acute monocytic leukemia: a case report. J Med Case Rep. [Internet]. 2022 [cited 2024 Aug 21];16(1):466. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9758892/

2. Beketova T, Mordechaev E, Murillo B, Schlesinger MD. Leukemic retinopathy: a diagnostic clue for initial detection and prognosis of leukemia. Creus [Internet]. 2023 [cited 2024 Sep 21];15(12):e50587. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10788118/

Submitted for publication: December 17, 2024.
Accepted for publication: January 15, 2025.

Informed consent was obtained from all patients included in this study.

Funding: This study received no specific financial support.

Disclosure of potential conflicts of interest: The authors declare no potential conflicts of interest.